Drug – bio-affecting and body treating compositions – Deodorants – For application to waste materials – solid or liquid refuse...
Patent
1997-04-29
1999-03-02
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Deodorants
For application to waste materials, solid or liquid refuse...
424 765, 424 766, 424 768, 424470, 510109, 510191, 510363, 510446, 510488, 514960, 514961, E03D 902
Patent
active
058767070
ABSTRACT:
The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by exposure to aqueous streams. The present invention also provides a simple and reliable method for controlled dispensing of such tableted formulations into a liquid stream that is particularly advantageous for use in micro-gravity environments, such as spacecraft urinal systems.
REFERENCES:
patent: 4155868 (1979-05-01), Kaplan et al.
patent: 4272393 (1981-06-01), Gergely
patent: 4647458 (1987-03-01), Ueno et al.
patent: 4749411 (1988-06-01), Chapin
patent: 4814095 (1989-03-01), Puchta et al.
patent: 4863445 (1989-09-01), Mayhan et al.
patent: 4940580 (1990-07-01), Sangekar et al.
patent: 5019346 (1991-05-01), Richter et al.
patent: 5313672 (1994-05-01), Luedtke et al.
patent: 5328633 (1994-07-01), Hasting et al.
patent: 5384062 (1995-01-01), Eoga et al.
patent: 5398347 (1995-03-01), Luedtke et al.
patent: 5458888 (1995-10-01), Chen
Birbara Philip J.
Rethke Donald W.
Bonzagni Esq. Mary R.
Harrison Robert H.
United Technologies Corporation
LandOfFree
Extended-release chemical formulation in tablet form for urine p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended-release chemical formulation in tablet form for urine p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended-release chemical formulation in tablet form for urine p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419631